GRAIL Growth, Revenue, Number of Employees and Funding

Overview

Location:
Total Funding:$1.6B
Industry:Biotech
Founded:2016
Lead Investor(s):Ally Bridge Group
Press

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • GRAIL's estimated revenue is currently $61.1M per year.
  • GRAIL received $300.0M in venture funding in May 2018.
  • GRAIL's estimated revenue per employee is $144716
  • GRAIL's total funding is $1.6B.

Employee Data

  • GRAIL has 422 Employees.
  • GRAIL grew their employee count by 5% last year.
  • GRAIL currently has 56 job openings.

Executive Contacts

NameTitle
Jason WongDirector, Supply Chain
Jason CarlsonSenior Director, Clinical Data Management
Daniel CivelloDirector, Clinical Data Science
Amy MaierDirector, Clinical Compliance
Kelsey GrossmanAssociate Director, Corporate Communications
Teresa TollerDirector Talent Acquisition
Beth ChangMedical Director
Gregory AlexanderDirector Biostatistics
Kalyani ChilukuriAssociate Director, Clinical Data Management
Anne-Renee HartmanVice President Clinical Development

What Is GRAIL?

GRAIL is a life sciences company whose mission is to detect cancer early, when it can be cured. GRAIL is using the power of high-intensity sequencing, population-scale clinical trials, and state of the art Computer Science and Data Science to enhance the scientific understanding of cancer biology and develop blood tests for early-stage cancer detection. The company has secured over $1B in venture funding led by ARCH Venture Partners and including Amazon, Bezos Expeditions, Bill Gates, Bristol-Myers Squibb, Celgene, GV, Illumina, Johnson & Johnson Innovation, Merck, McKesson Ventures, Sutter Hill Ventures, Tencent, Varian Medical Systems, and other financial partners. If you're ready to join a mission with meaning, bring your passion to GRAIL. Together we will make history in the fight against cancer.

keywords:N/A

422

Number of Employees

$61.1M

Revenue (est)

56

Current Jobs

5%

Employee Growth %

$1.6B

Total Funding

$2.46B

Valuation

N/A

Accelerator

N/A

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
DiaCarta
$6.2M4310%$53M
Mission Bio
$10.7M7445%
Rigel Pharmaceu...
$42M2904%
ProTrials Resea...
$26.4M1823%
Trace Genomics
$5.9M4137%
Advanced Cell D...
$25.7M1788%
CellMax Life
$5.7M4011%$9M
Vaxart
$4.2M33-15%$58.6M
Full Spectrum A...
$6M425%
Calysta
$7.1M49-2%

GRAIL News

09/03/2019 - GRAIL Appoints Rodger Currie as Head of Government Affairs ...

MENLO PARK, Calif.--(BUSINESS WIRE)--GRAIL, Inc., a healthcare company whose mission is to detect cancer early, when it can be cured, ...

09/08/2019 - Y Combinator-backed Holy Grail is using machine learning to build better batteries

For a long, long time, renewable energy proponents have considered advancements in battery technology to be the Holy Grail of the industry.

09/03/2019 - Autonomous Vehicles: Holy Grail or Poisoned Chalice?

"You must choose. But choose wisely. For as the true Grail will bring you life, the false Grail will take it from you." - The Grail Knight, "Indiana ...

GRAIL Funding

DateAmountRoundLead InvestorsReference
2017-03-02$900.0MBArch Venture PartnersArticle
2017-11-23$1211.7MBARCH Venture PartnersArticle
2018-05-22$300.0MCAlly Bridge GroupArticle

GRAIL Executive Hires

DateNameTitleReference
2017-08-03Bill RastetterChief Executive OfficerArticle
2017-12-15Jennifer CookCEOArticle
2018-07-10George GolumbeskiPresidentArticle
2018-12-11Catherine FriedmanChairmanArticle